Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-8-13
pubmed:abstractText
To evaluate the efficacy of a combined therapy with levocabastine hydrochloride ophthalmic suspension and pemirolast potassium ophthalmic solution compared to single therapy with levocabastine hydrochloride ophthalmic suspension alone.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1423-0267
pubmed:author
pubmed:copyrightInfo
(c) 2008 S. Karger AG, Basel.
pubmed:issnType
Electronic
pubmed:volume
222
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
232-9
pubmed:meshHeading
pubmed-meshheading:18463425-Adolescent, pubmed-meshheading:18463425-Adult, pubmed-meshheading:18463425-Aged, pubmed-meshheading:18463425-Aged, 80 and over, pubmed-meshheading:18463425-Child, pubmed-meshheading:18463425-Conjunctivitis, Allergic, pubmed-meshheading:18463425-Drug Therapy, Combination, pubmed-meshheading:18463425-Eosinophils, pubmed-meshheading:18463425-Female, pubmed-meshheading:18463425-Histamine H1 Antagonists, Non-Sedating, pubmed-meshheading:18463425-Humans, pubmed-meshheading:18463425-Leukocyte Count, pubmed-meshheading:18463425-Male, pubmed-meshheading:18463425-Middle Aged, pubmed-meshheading:18463425-Ophthalmic Solutions, pubmed-meshheading:18463425-Piperidines, pubmed-meshheading:18463425-Pyridines, pubmed-meshheading:18463425-Pyrimidinones, pubmed-meshheading:18463425-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
The effect of a combined therapy with a histamine H1 antagonist and a chemical mediator release inhibitor on allergic conjunctivitis.
pubmed:affiliation
Department of Ophthalmology, International University of Health and Welfare, Mita Hospital, Tokyo, Japan. fujishima@iuhw.ac.jp
pubmed:publicationType
Journal Article, Randomized Controlled Trial